share_log

ATyr Pharma(LIFE.US) Director Buys US$87,500 in Common Stock

moomoo News ·  Jun 3 17:09

$aTyr Pharma (LIFE.US)$ Director COUGHLIN TIMOTHY purchased 50,000 shares of common stock on May 30, 2024 at an average price of $1.75 for a total value of $87,500.

1717448983545642584.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment